Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
Authors
Keywords
-
Journal
IMMUNITY
Volume 53, Issue 6, Pages 1315-1330.e9
Publisher
Elsevier BV
Online
2020-11-25
DOI
10.1016/j.immuni.2020.11.015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The reproductive number of COVID-19 is higher compared to SARS coronavirus
- (2020) Ying Liu et al. JOURNAL OF TRAVEL MEDICINE
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B
- (2020) Wenjun Wang et al. Nature Nanotechnology
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2
- (2020) Alba Grifoni et al. Cell Host & Microbe
- SARS-CoV-2 Vaccines: Status Report
- (2020) Fatima Amanat et al. IMMUNITY
- Human neutralizing antibodies elicited by SARS-CoV-2 infection
- (2020) Bin Ju et al. NATURE
- Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
- (2020) Dora Pinto et al. NATURE
- Developing Covid-19 Vaccines at Pandemic Speed
- (2020) Nicole Lurie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapid COVID-19 vaccine development
- (2020) Barney S. Graham SCIENCE
- Development of an inactivated vaccine candidate for SARS-CoV-2
- (2020) Qiang Gao et al. SCIENCE
- Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
- (2020) Shibo Jiang et al. TRENDS IN IMMUNOLOGY
- Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
- (2020) Hui Wang et al. CELL
- A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
- (2020) Lianpan Dai et al. CELL
- A Thermostable mRNA Vaccine against COVID-19
- (2020) Na-Na Zhang et al. CELL
- Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis in mice
- (2020) James Brett Case et al. Cell Host & Microbe
- A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice
- (2020) Dorottya Laczkó et al. IMMUNITY
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Feng-Cai Zhu et al. LANCET
- A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
- (2020) Jingyun Yang et al. NATURE
- Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
- (2020) Noe B. Mercado et al. NATURE
- ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
- (2020) Neeltje van Doremalen et al. NATURE
- COVID-19 vaccine development and a potential nanomaterial path forward
- (2020) Matthew D. Shin et al. Nature Nanotechnology
- COVIDep: a web-based platform for real-time reporting of vaccine target recommendations for SARS-CoV-2
- (2020) Syed Faraz Ahmed et al. Nature Protocols
- Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
- (2020) Thomas F. Rogers et al. SCIENCE
- Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
- (2020) Jose Mateus et al. SCIENCE
- Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits
- (2020) Supriya Ravichandran et al. Science Translational Medicine
- COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses
- (2020) Muhammad Adnan Shereen et al. Journal of Advanced Research
- Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory B cell maturation
- (2020) Hannah G. Kelly et al. JCI Insight
- A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
- (2020) Ahmed O. Hassan et al. CELL
- Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies
- (2020) Bingfeng Liu et al. Cellular & Molecular Immunology
- Zika Virus-Immune Plasmas from Symptomatic and Asymptomatic Individuals Enhance Zika Pathogenesis in Adult and Pregnant Mice
- (2019) Byoung-Shik Shim et al. mBio
- Remembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination
- (2019) Anna-Karin E. Palm et al. Frontiers in Immunology
- Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers
- (2018) Talar Tokatlian et al. SCIENCE
- Viral-Induced Enhanced Disease Illness
- (2018) Maria K. Smatti et al. Frontiers in Microbiology
- Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
- (2013) Masaru Kanekiyo et al. NATURE
- Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
- (2013) J. Jardine et al. SCIENCE
- Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
- (2012) Chien-Te Tseng et al. PLoS One
- Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing
- (2012) Hatem A. Elshabrawy et al. PLoS One
- Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin
- (2012) B. Zakeri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- From Vaccines to Memory and Back
- (2010) Federica Sallusto et al. IMMUNITY
- The spike protein of SARS-CoV — a target for vaccine and therapeutic development
- (2009) Lanying Du et al. NATURE REVIEWS MICROBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More